9 reports of this reaction
3.6% of all SULFACETAMIDE SODIUM, SULFUR reports
#1 most reported adverse reaction
PAIN is the #1 most commonly reported adverse reaction for SULFACETAMIDE SODIUM, SULFUR, manufactured by Aurobindo Pharma Limited. There are 9 FDA adverse event reports linking SULFACETAMIDE SODIUM, SULFUR to PAIN. This represents approximately 3.6% of all 251 adverse event reports for this drug.
Patients taking SULFACETAMIDE SODIUM, SULFUR who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among SULFACETAMIDE SODIUM, SULFUR users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for SULFACETAMIDE SODIUM, SULFUR:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 9 FDA reports for SULFACETAMIDE SODIUM, SULFUR. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 3.6% of all adverse event reports for SULFACETAMIDE SODIUM, SULFUR, making it one of the most commonly reported side effect.
If you experience pain while taking SULFACETAMIDE SODIUM, SULFUR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.